PL EN


Preferences help
enabled [disable] Abstract
Number of results
2018 | 107 | 171-184
Article title

Helicobacter pylori infection: from biology to clinical features

Content
Title variants
Languages of publication
EN
Abstracts
EN
The discovery of bacterium Helicobacter pylori and the association of its occurrence with gastritis and peptic ulcer disease, was one of the most significant events of the 20th century. Almost 40 years have passed since that event, but we are still far from fully understanding of the impact of H. pylori infection on the human body. It is confirmed, that the infection causes chronic gastritis, which increases the risk of diseases such as: duodenal and/or gastric ulcer, gastric cancer and gastric MALT lymphoma. Nevertheless, constantly appear new studies linking H. pylori with many other disorders, often not directly related to the digestive system. Cardiovascular, neurological, hematological, dermatological, metabolic and also gynecological diseases are in sphere of assumptions. The authors of the following work attempted to select key information available in the medical literature on the discovery of H. pylori, epidemiology and pathophysiology of infection, as well as diseases to which it predisposes and the latest methods of eradication.
Discipline
Year
Volume
107
Pages
171-184
Physical description
Contributors
  • Faculty of Medicine, Wroclaw Medical University, J. Mikulicza-Radeckiego 5, 50-345 Wroclaw, Poland
  • Faculty of Medicine, Wroclaw Medical University, J. Mikulicza-Radeckiego 5, 50-345 Wroclaw, Poland
author
  • Chair and Department of Pharmacology and Pharmacodynamics, Medical University of Lublin, Chodzki 4a, 20-093, Lublin, Poland
  • Faculty of Medicine, Wroclaw Medical University, J. Mikulicza-Radeckiego 5, 50-345 Wroclaw, Poland
  • Department of Gastroenterology and Hepatology, Wroclaw Medical University, 213 Borowska Str., 50-556 Wroclaw, Poland
author
  • Department of Gastroenterology and Hepatology, Wroclaw Medical University, 213 Borowska Str., 50-556 Wroclaw, Poland
References
  • 1. Goodwin CS, Worsley BW. Microbiology of Helicobacter pylori. Gastroenterol Clin North Am 22(1) (1993) 5–19
  • 2. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet (London, England) 1(8390) (1984) 1311–5
  • 3. Copeland CE, Stahlfeld K. Two Tall Poppies and the Discovery of Helicobacter Pylori. J Am Coll Surg 214(2) (2012) 237–41.
  • 4. Watts G. Nobel prize is awarded to doctors who discovered H pylori. BMJ 331(7520) (2005) 795
  • 5. Linz B, Balloux F, Moodley Y, Manica A, Liu H, Roumagnac P, et al. An African origin for the intimate association between humans and Helicobacter pylori. Nature 445(7130) (2007) 915–8
  • 6. Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, et al. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology 153(2) (2017) 420–9
  • 7. Rajindrajith S, Devanarayana NM, de Silva HJ. Helicobacter pylori infection in children. Saudi J Gastroenterol 15(2) (2009) 86–94
  • 8. Grübel P, Huang L, Masubuchi N, Stutzenberger FJ, Cave DR. Detection of Helicobacter pylori DNA in houseflies (Musca domestica) on three continents. Lancet 352(9130) (1998) 788–9
  • 9. Jafri W, Yakoob J, Abid S, Siddiqui S, Awan S, Nizami S. Helicobacter pylori infection in children: population-based age-specific prevalence and risk factors in a developing country. Acta Paediatr 99(2) (2009) 279–82
  • 10. Fox JG, Dangler CA, Taylor NS, King A, Koh TJ, Wang TC. High-salt diet induces gastric epithelial hyperplasia and parietal cell loss, and enhances Helicobacter pylori colonization in C57BL/6 mice. Cancer Res 59(19) (1999) 4823–8
  • 11. Perry S, de la Luz Sanchez M, Yang S, Haggerty T, Hurst P, Perez-Perez G, et al. Gastroenteritis and Transmission of Helicobacter pylori Infection in Households. Emerg Infect Dis 12(11) (2006) 1701–8
  • 12. Graham DY, Malaty HM, Evans DG, Evans DJ, Klein PD, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology 100(6) (1991) 1495–501
  • 13. Magalhães A, Reis CA. Helicobacter pylori adhesion to gastric epithelial cells is mediated by glycan receptors. Brazilian J Med Biol Res = Rev Bras Pesqui medicas e Biol 43(7) (2010) 611–8
  • 14. Rubinsztein-Dunlop S, Guy B, Lissolo L, Fischer H. Identification of two new Helicobacter pylori surface proteins involved in attachment to epithelial cell lines. J Med Microbiol 54(5) (2005) 427–34
  • 15. Kusters JG, van Vliet AHM, Kuipers EJ. Pathogenesis of Helicobacter pylori Infection. Clin Microbiol Rev 19(3) (2006) 449–90
  • 16. Andersen LP. Colonization and Infection by Helicobacter pylori in Humans. Helicobacter 12(s2) (2007) 12–5
  • 17. Blaser MJ, Atherton JC. Helicobacter pylori persistence: biology and disease. J Clin Invest 113(3) (2004) 321–33
  • 18. Moss SF, Legon S, Bishop AE, Polak JM, Calam J. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet (London, England) 340(8825) (1992) 930–2
  • 19. Gillen D, EL–Omar EM, Wirz AA, Ardill JES, McColl KEL. The acid response to gastrin distinguishes duodenal ulcer patients from Helicobacter pylori–infected healthy subjects. Gastroenterology 114(1) (1998) 50–7
  • 20. Koike T, Ohara S, Sekine H, Iijima K, Abe Y, Kato K, et al. Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion. Gut 49(3) (2001) 330–4
  • 21. Ahn HJ, Lee DS. Helicobacter pylori in gastric carcinogenesis. World J Gastrointest Oncol 7(12) (2015) 455–65
  • 22. El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 124(5) (2003) 1193–201
  • 23. Ohnishi N, Yuasa H, Tanaka S, Sawa H, Miura M, Matsui A, et al. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci 105(3) (2008) 1003–8
  • 24. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet (London, England) 338(8776) (1991) 1175–6
  • 25. Sagaert X, Van Cutsem E, De Hertogh G, Geboes K, Tousseyn T. Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development. Nat Rev Gastroenterol Hepatol 7(6) (2010) 336–46
  • 26. Ullrich A, Fischbach W, Blettner M. Incidence of gastric B-cell lymphomas: a population-based study in Germany. Ann Oncol Off J Eur Soc Med Oncol 13(7) (2002) 1120–7
  • 27. Zullo A, Hassan C, Ridola L, Repici A, Manta R, Andriani A. Gastric MALT lymphoma: old and new insights. Ann Gastroenterol 27(1) (2014) 27–33
  • 28. Hussell T, Isaacson PG, Crabtree JE, Spencer J. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet (London, England) 342(8871) (1993) 571–4
  • 29. Hu Q, Zhang Y, Zhang X, Fu K. Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori infection: a review of current diagnosis and management. Biomark Res 4 (2016) 15
  • 30. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog risks to humans 61 (1994) 1–241.
  • 31. Franceschi F, Tortora A, Gasbarrini G, Gasbarrini A. Helicobacter pylori and Extragastric Diseases. Helicobacter 19 (2014) 52–8
  • 32. Choe YH, Kim SK, Hong YC. The relationship between Helicobacter pylori infection and iron deficiency: seroprevalence study in 937 pubescent children. Arch Dis Child 88(2) (2003) 178
  • 33. Kaptan K, Beyan C, Ural AU, Cetin T, Avcu F, Gülşen M, et al. Helicobacter pylori--is it a novel causative agent in Vitamin B12 deficiency? Arch Intern Med 160(9) (2000) 1349–53
  • 34. Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet [Internet] 352(9131) (1998) 878
  • 35. Kohda K, Kuga T, Kogawa K, Kanisawa Y, Koike K, Kuroiwa G, et al. Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura. Br J Haematol 118(2) (2002) 584–8
  • 36. Tag HS, Lee HS, Jung S-H, Kim B-K, Kim S-B, Lee A, et al. Effects of Helicobacter pylori eradication in patients with immune thrombocytopenic purpura. Korean J Hematol 45(2) (2010) 127–32
  • 37. Benson J, Rahim RA, Agrawal R. Newly arrived refugee children with Helicobacter pylori are thinner than their non-infected counterparts. Aust J Prim Health 23(1) (2017) 92
  • 38. Szlachcic A. The link between Helicobacter pylori infection and rosacea. J Eur Acad Dermatol Venereol 16(4) (2002) 328–33
  • 39. Chiu Y-C, Tai W-C, Chuah S-K, Hsu P-I, Wu D-C, Wu K-L, et al. The Clinical Correlations of Helicobacter pylori Virulence Factors and Chronic Spontaneous Urticaria. Gastroenterol Res Pract 2013 (2013) 1–6
  • 40. Altschuler E. Gastric Helicobacter pylori infection as a cause of idiopathic Parkinson disease and non-arteric anterior optic ischemic neuropathy. Med Hypotheses 47(5) (1996) 413–4
  • 41. Dobbs RJ, Dobbs SM, Weller C, Bjarnason IT, Oxlade NL, Charlett A, et al. Role of Chronic Infection and Inflammation in the Gastrointestinal Tract in the Etiology and Pathogenesis of Idiopathic Parkinsonism. Part 1: Eradication of Helicobacter in the Cachexia of Idiopathic Parkinsonism. Helicobacter 10(4) (2005) 267–75
  • 42. Bjarnason IT, Charlett A, Dobbs RJ, Dobbs SM, Ibrahim MAA, Kerwin RW, et al. Role of Chronic Infection and Inflammation in the Gastrointestinal Tract in the Etiology and Pathogenesis of Idiopathic Parkinsonism. Part 2: Response of Facets of Clinical Idiopathic Parkinsonism to Helicobacter pylori Eradication. A randomized, Double-blind, Placebo-controlled Efficacy Study. Helicobacter 10(4) (2005) 276–87
  • 43. Pierantozzi M, Pietroiusti A, Brusa L, Galati S, Stefani A, Lunardi G, et al. Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations. Neurology 66(12) (2006) 1824–9
  • 44. Schulz JD, Hawkes EL, Shaw CA. Cycad toxins, Helicobacter pylori and parkinsonism: Cholesterol glucosides as the common denomenator. Med Hypotheses 66(6) (2006) 1222–6
  • 45. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 71(5) (1994) 437–9
  • 46. Alkout AM, Ramsay EJ, Mackenzie DA, Weir DM, Bentley AJ, Elton RA, et al. Quantitative assessment of IgG antibodies to Helicobacter pylori and outcome of ischaemic heart disease. FEMS Immunol Med Microbiol 29(4) (2000) 271–4
  • 47. Kowalski M, Rees W, Konturek PC, Grove R, Scheffold T, Meixner H, et al. Detection of Helicobacter pylori specific DNA in human atheromatous coronary arteries and its association to prior myocardial infarction and unstable angina. Dig Liver Dis 34(6) (2002) 398–402
  • 48. Xu Q, Schett G, Perschinka H, Mayr M, Egger G, Oberhollenzer F, et al. Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation 102(1) (2000) 14–20
  • 49. Hoffmeister A, Rothenbacher D, Bode G, Persson K, März W, Nauck MA, et al. Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified lipid profile. Arterioscler Thromb Vasc Biol 21(3) (2001) 427–32
  • 50. Kountouras J, Polyzos SA, Doulberis M, Zeglinas C, Artemaki F, Vardaka E, et al. Potential impact of Helicobacter pylori -related metabolic syndrome on upper and lower gastrointestinal tract oncogenesis. Metabolism 87 (2018) 18–24
  • 51. Azuma T, Suto H, Ito Y, Ohtani M, Dojo M, Kuriyama M, et al. Gastric leptin and Helicobacter pylori infection. Gut 49(3) (2001) 324–9
  • 52. Hosseinzadeh M, Khosravi A, Saki K, Ranjbar R. Evaluation of Helicobacter pylori infection in patients with common migraine headache. Arch Med Sci 5(5) (2011) 844–9
  • 53. Bagis T, Gumurdulu Y, Kayaselcuk F, Yilmaz ES, Killicadag E, Tarim E. Endoscopy in hyperemesis gravidarum and Helicobacter pylori infection. Int J Gynaecol Obstet 79(2) (2002) 105–9
  • 54. Figura N, Piomboni P, Ponzetto A, Gambera L, Lenzi C, Vaira D, et al. Helicobacter pylori infection and infertility. Eur J Gastroenterol Hepatol 14(6) (2002) 663–9
  • 55. Fukuda K, Kuroki T, Tajima Y, Tsuneoka N, Kitajima T, Matsuzaki S, et al. Comparative analysis of Helicobacter DNAs and biliary pathology in patients with and without hepatobiliary cancer. Carcinogenesis 23(11) (2002) 1927–31
  • 56. Enko D, Kriegshäuser G. Functional 13C-urea and glucose hydrogen/methane breath tests reveal significant association of small intestinal bacterial overgrowth in individuals with active Helicobacter pylori infection. Clin Biochem 50(1–2) (2017) 46–9
  • 57. Tabaru A, Gorguner M, Akgun M, Meral M, Sahin A. Helicobacter Pylori Infections in Chronic Obstructive Pulmonary Disease. Eurasian J Med 44(3) (2012) 144–8
  • 58. Malfertheiner P, Megraud F, O’Morain CA, Gisbert JP, Kuipers EJ, Axon AT, et al. Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report. Gut 66(1) (2017) 6–30
  • 59. Malfertheiner P, Megraud F, O’Morain CA, Atherton J, Axon ATR, Bazzoli F, et al. Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report. Gut 61(5) (2012) 646–64
  • 60. Liu WZ, Xie Y, Cheng H, Lu NH, Hu FL, Zhang WD, et al. Fourth Chinese National Consensus Report on the management of Helicobacter pylori infection. J Dig Dis 14(5) (2013) 211–21
  • 61. Chey WD, Wong BCY, Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection. Am J Gastroenterol 102(8) (2007) 1808–25
  • 62. Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut 59(8) (2010) 1143–53
  • 63. Papastergiou V, Georgopoulos SD, Karatapanis S. Treatment of Helicobacter pylori infection: meeting the challenge of antimicrobial resistance. World J Gastroenterol 20(29) (2014) 9898–911
  • 64. Phan TN, Santona A, Tran VH, Tran TNH, Le VA, Cappuccinelli P, et al. High rate of levofloxacin resistance in a background of clarithromycin- and metronidazole-resistant Helicobacter pylori in Vietnam. Int J Antimicrob Agents 45(3) (2015) 244–8
  • 65. Maes ML, Fixen DR, Linnebur SA. Adverse effects of proton-pump inhibitor use in older adults: a review of the evidence. Ther Adv Drug Saf 8(9) (2017) 273–97
  • 66. Zeng M, Mao X-H, Li J-X, Tong W-D, Wang B, Zhang Y-J, et al. Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 386(10002) (2015) 1457–64
Document Type
article
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.psjd-3083fee5-b47f-4a63-a7b4-fa9df5f6a0e4
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.